Navigation Links
Global Market for Minimally Invasive Vertebral Compression Fracture Treatments Will Reach $925 Million by 2022
Date:9/3/2014

BURLINGTON, Mass., Sept. 3, 2014 /PRNewswire/ -- Decision Resources Group finds that the global market for minimally invasive vertebral compression fracture (MIVCF) treatments will reach a value of $925 million by 2022, driven by an increasing prevalence of osteoporosis, which is largely the result of an aging population. In addition, marketing activity and positive clinical data will spur increasing use of these devices in the tumor and trauma indications, supporting overall procedure volumes.

Other key findings from Decision Resources Group's coverage of the global MIVCF treatment market:

  • Global price declines: Price competition and economic challenges will negatively impact average device prices. Financial concerns will be particularly evident in European countries such as Italy, where the effects of the eurozone crisis are still lingering.
  • Rapidly expanding revenues in Japan: The Japanese market will see the strongest revenue growth, driven by the recent reimbursement approval and subsequent rapid adoption of Medtronic's Kyphoplasty product in the vertebral augmentation segment.
  • Steady U.S. forecast: Despite issues with reimbursement that hindered procedure volume growth in 2013, the United States market will remain the largest but lowest growth market through 2022; currently this market represents approximately two-thirds of total global revenues.

Comments from Decision Resources Group Senior Analyst Brady Baker:

  • "Medtronic holds the majority of revenues in the global MIVCF treatment market, largely as a result of its stronghold in the vertebral augmentation space. Additional competitors will look to capture market share, however, by launching innovative and lower-cost products. For example, both CareFusion and DFINE have gained strong market shares by incorporating unique features and low price points into their product portfolios."

Comments from Decision Resources Group Analyst Valentina Lim:

  • "Poor or nonexistent reimbursement will limit overall revenue expansion in some markets. For example, unfavorable reimbursement for vertebroplasty—particularly in Australia and Japan—will somewhat limit growth in the Asia Pacific region."

Additional Resources:

About Decision Resources Group

Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group 
Christopher Comfort  
781-993-2597  
ccomfort@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO


'/>"/>
SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Bone Cement and Accessories Market Is Set to Expand from $630 Million in 2013 to Over $1 Billion by 2022
2. Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference
3. CytoSorbents to Present at the 2014 Rodman & Renshaw Annual Global Investment Conference
4. Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
5. RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
6. Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014
7. Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
8. Global Markets and Technologies for Molecular Imaging Devices
9. Bariatric Surgery: Global Markets for Services and Devices
10. Acute Heart Failure Global Clinical Trials Review, H2, 2014
11. Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016 Aesthetic Devices - Medical Devices Pipeline ... report, "Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" ... stage. This report is prepared using ... by GlobalData,s team of industry experts. *Note: Certain ... based on the availability and relevance of data in ...
(Date:2/8/2016)... 2016  Ventana Medical Systems, Inc. (Ventana), a member ... world,s top oncologists, pathologists, research scientists and healthcare ... annual Tucson Symposium March 8-9 to learn ... outcomes in cancer research and treatments that will ... Thomas Grogan , annually draws more than 500 ...
(Date:2/8/2016)... LEAWOOD, Kan. , Feb. 8, 2016 ... held organization that formerly specialized in the ... facilities, recently announced that it has divided ... Nueterra Capital. While Nueterra Capital will continue ... advisory services, NueHealth will operate a national ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Establishment Labs, ... of Dr. David Hung to the company´s Board of Directors. , “We ... class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of Establishment ...
(Date:2/9/2016)... ... 09, 2016 , ... ZipHearing.com is proud to ... hearing aids , increase industry transparency, and promote awareness of hearing solutions ... “For the average consumer, the hearing aid industry is esoteric and difficult to ...
(Date:2/9/2016)... ... February 09, 2016 , ... Sir Grout, ... , is proud to announce that many of their franchises have received the ... The hard surface restoration franchises received customer recognition through positive reviews and testimonials, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... its newly redesigned website, federallabs.org . The site houses a wealth of ... available federal technologies through the process called technology transfer (T2). As a network ...
(Date:2/8/2016)... ... ... man who has struggled to quit smoking, a man who has struggled with hair loss ... to his problems – and he did. Now Nabat, a serial entrepreneur featured as the ... inventions to the world and better people's lives. His own experience with nicotine addiction led ...
Breaking Medicine News(10 mins):